WORLD
Britain's GSK Racked Up $1.9 Billion in COVID-related Sales in 2021, Driven Largely by ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Britain’s GSK racked up $1.9 billion in COVID-related sales in 2021, driven largely by its antibody drug Sotrovimab, as it beat quarterly forecasts in its first earnings report since rejecting Unilever's bid for its consumer arm ...'
Britain’s GSK racked up $1.9 billion in COVID-related sales in 2021, driven largely by its antibody drug Sotrovimab, as it beat quarterly forecasts in its first earnings report since rejecting Unilever's bid for its consumer arm https://t.co/93H3b6lSe0 pic.twitter.com/wiGdyoA8Ax— Reuters (@Reuters) February 9, 2022
(The above story first appeared on LatestLY on Feb 09, 2022 10:13 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
